Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00012103 · ClinicalTrials.gov registry record · NA
Computed Tomography for Early Detection of Cancer in Women Who Are at Risk for Lung Cancer
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
NCT00012103 is a NA study that has completed, run by NYU Langone Health.
The verdict
NCT00012103, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
RATIONALE: Imaging procedures such as computed tomography may improve the ability to detect lung cancer earlier. PURPOSE: Screening and diagnostic study of computed tomography in women who are at risk for lung cancer.
Interventions
- OTHER sputum cytology
- OTHER screening questionnaire administration
- PROCEDURE bronchoscopy
- PROCEDURE bronchoscopic and lung imaging studies
- OTHER bronchoalveolar lavage
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00012103
The ClinicalTrials.gov registry entry for NCT00012103 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which sputum cytology is the first listed.
NCT00012103 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00012103 about?
NCT00012103 is a clinical study titled "Computed Tomography for Early Detection of Cancer in Women Who Are at Risk for Lung Cancer". RATIONALE: Imaging procedures such as computed tomography may improve the ability to detect lung cancer earlier. PURPOSE: Screening and diagnostic study of computed tomography in women who are at risk for lung cancer.
What is the current status of trial NCT00012103?
This trial is currently completed. It is a NA study. The study started on 1999-09.
What interventions are being tested in trial NCT00012103?
The interventions under investigation include: sputum cytology (OTHER), screening questionnaire administration (OTHER), bronchoscopy (PROCEDURE), bronchoscopic and lung imaging studies (PROCEDURE), bronchoalveolar lavage (OTHER).
Who is sponsoring clinical trial NCT00012103?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.